-Developing the CardiaZn, a bioresorbable metallic stent to treat congenital heart defects in neonates.-Selected by the FDA in 2023 as a Break Through Technology and the first device accepted into the FDA's new Total Product Life Cycle Advisory Program (TAP).-Principal Investigator on a $3.4 million SBIR Fast Track grant from the National Institutes of Health.

-Developer and marketer of pediatric angiography catheters, sheaths and guide wires.-Over 80,000 babies in 25 countries successfully treated to date with PediaVascular's devices.www.pediavascular.com

-501.c.3 non-profit that champions the R&D of pediatric medical devices and provides commercialization guidance to pediatric research institutions.www.pediaworks.org

Developer of pediatric transcatheter valveshttps://www.polyvascular.com/

-Founded and led CSF Therapeutics from concept through pre-clinical testing of a class III device for treating neurodegenerative diseases. -Raised series A venture funding. -Co-inventor on core patent.

-Spun out CSF Therapeutics-Managed the formation and initial funding of Intelect Medical (acquired by Boston Scientific).

-One year sabbatical to help the City of Cleveland recruit and grow high tech companies. -Appointed by mayor Jane Campbell to newly-created cabinet position.

-Provider of outsourced IT services to US and European businesses. -Contracted by Microsoft to beta test the .Net platform with its multinational clients.-http://www.computerworld.com/article/2587250/app-development/fewer-plumbers.html.

-Developed five year adoption projections for commercial and consumer automotive GPS systems, specified price points and required functionality.

-Spearheaded the development of an adhesive that was installed in 90% of US cars manufactured between 1995 and 2000. -Awarded sales rep of the year within a division of 90 reps.